Co-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and Hypercholesterolemia

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Cecilia Martínez-JiménezLuz María Martínez

Abstract

The high index of simultaneous incidence of hypertension and hypercholesterolemia in the population of many countries demands the preparation of more efficient drugs. Therefore, there is a significant area of opportunity to provide as many alternatives as possible to treat these illnesses. Taking advantage of the solubility enhancement that can be achieved when an active pharmaceutical ingredient (API) is obtained and stabilized in its amorphous state, in the present work, new drug-drug co-amorphous formulations (Simvastatin SIM- Nifedipine NIF) with enhanced solubility and stability were prepared and characterized. Results show that the co-amorphous system (molar ratio 1:1) is more soluble than the pure commercial APIs studied separately. Aqueous dissolution profiles showed increments of solubility of 3.7 and 1.7 times for SIM and NIF, correspondingly, in the co-amorphous system. The new co-amorphous formulations, monitored in time, (molar fractions 0.3, 0.5 and 0.7 of SIM) remained stable in the amorphous state for more than one year when stored at room temperature and did not show any signs of crystallization when re-heating. Inspection on the remainder of a sample after six hours of dissolution showed no recrystallization, ...Continue Reading

References

Jun 16, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ching-Ling ChengChen-Hsi Chou
Jul 11, 2006·The American Journal of Cardiology·Nathan D WongG Rhys Williams
Feb 19, 2008·British Journal of Clinical Pharmacology·Thomas M MacDonald, Steven V Morant
Aug 16, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Fang ZhangThomas Rades
Aug 6, 2011·The AAPS Journal·Leslie Z BenetTudor I Oprea
Feb 23, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Korbinian LöbmannRiikka Laitinen
Apr 14, 2012·International Journal of Pharmaceutics·Ana Maria Sierra VillarLyda Halbaut Bellowa
May 10, 2012·International Journal of Pharmaceutics·Riikka LaitinenThomas Rades
Dec 19, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Thomas TaupitzSandra Klein
Apr 24, 2014·Expert Opinion on Drug Delivery·Holger GrohganzThomas Rades
Dec 3, 2014·International Journal of Pharmaceutics·Luz María MartínezNahida González
Feb 13, 2015·Pharmaceutical Research·Sujinda KeratichewanunJittima Chatchawalsaisin
Jun 13, 2015·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Branislava Ivanovic, Marijana Tadic
Jan 26, 2016·Advanced Drug Delivery Reviews·Swapnil Jayant DengaleKorbinian Löbmann
Jun 9, 2016·Expert Opinion on Drug Delivery·Ossi KorhonenRiikka Laitinen
Dec 17, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Luz María MartínezSamuel Castro
Jun 27, 2017·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Luz María MartínezFabiola Castorena-Torres

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
infrared spectroscopy

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Luz María MartínezSamuel Castro
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Korbinian LöbmannRiikka Laitinen
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Korbinian LöbmannThomas Rades
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Luz María MartínezFabiola Castorena-Torres
© 2022 Meta ULC. All rights reserved